NTCOC
FBIO icon

Northern Trust Company of Connecticut’s Fortress Biotech FBIO Stock Holding History

Northern Trust Company of Connecticut’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$13K Hold
325
– – ﹤0.01% 1995
2013
Q3 		$34K Hold
325
– – ﹤0.01% 1940
2013
Q2 		$42K Buy
+325
New +$47.9K ﹤0.01% 1896

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Northern Trust Company of Connecticut's FBIO Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Fortress Biotech (FBIO) position steady in Q4 2013 at 325 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Northern Trust Company of Connecticut first reported a position in FBIO in Q2 2013 and has held it in 3 quarters since. The position peaked at $42K in Q2 2013. 60 funds tracked by Wall St. Rank hold FBIO as of Q4 2013.

  • Northern Trust Company of Connecticut held 325 shares of Fortress Biotech worth $13K as of Q4 2013.
  • Northern Trust Company of Connecticut left its Fortress Biotech share count unchanged in Q4 2013.
  • Fortress Biotech made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1995 holding.
  • Northern Trust Company of Connecticut first reported a position in Fortress Biotech in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Fortress Biotech position peaked at $42K in Q2 2013.
  • 60 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.